Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-12-23
pubmed:abstractText
Graft-versus-host disease (GVHD) is a multistep disease process following allogeneic bone marrow transplantation (BMT). It has been postulated that the induction of acute GVHD requires the presence of Peyer patches (PPs). A new tumor necrosis factor (TNF)-deficient strain has been developed that totally lacks PPs and displays the defects characteristic of TNF ablation but not lymphotoxin-associated defects characterized by lack of both PPs and lymph nodes. To determine the necessity of PPs in acute lethal GVHD induction, we transplanted full major histocompatibility complex (MHC)-mismatched grafts into myeloablated TNF knockout recipients. No differences in the survival or GVHD-associated histopathologic lesions were observed between the recipients. We conclude that neither PPs nor host TNF-alpha is required for the development of acute lethal GVHD in mice that undergo myeloablative conditioning and allogeneic BMT.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-10725718, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-11267498, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-12424195, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-12524535, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-14563643, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-15003318, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-1522226, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-15240671, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-15664162, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-15832287, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-3486193, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-8171322, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-8513499, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-8691140, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-8879212, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-9177215, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-9223320, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-9368616, http://linkedlifedata.com/resource/pubmed/commentcorrection/16160014-9565643
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
107
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
410-2
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation.
pubmed:affiliation
Department of Microbiology and Immunology, University of Nevada School of Medicine, Mail Stop 199, Reno, NV 89557, USA. lwelniak@unr.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural